Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 174 entries
Sorted by: Best Match Show Resources per page
A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.

Clinical and translational allergy

Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J.
PMID: 26509001
Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015.

BACKGROUND: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors' perception of a...

Cite
Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36doi: 10.1186/s13601-015-0080-9.
Hellings, P. W., Muraro, A., Fokkens, W., Mullol, J., Bachert, C., Canonica, G. W., Price, D., Papadopoulos, N., Scadding, G., Rasp, G., Demoly, P., Murray, R., & Bousquet, J. (2015). A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clinical and translational allergy, 536. https://doi.org/10.1186/s13601-015-0080-9
Hellings, Peter W, et al. "A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress." Clinical and translational allergy vol. 5 (2015): 36. doi: https://doi.org/10.1186/s13601-015-0080-9
Hellings PW, Muraro A, Fokkens W, Mullol J, Bachert C, Canonica GW, Price D, Papadopoulos N, Scadding G, Rasp G, Demoly P, Murray R, Bousquet J. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015 Oct 27;5:36. doi: 10.1186/s13601-015-0080-9. eCollection 2015. PMID: 26509001; PMCID: PMC4621924.
Copy Download .nbib Format: NLM
Sleep Disturbances Following Traumatic Brain Injury.

Current treatment options in neurology

Rao V, Rollings P.
PMID: 11734105
Curr Treat Options Neurol. 2002 Jan;4(1):77-87. doi: 10.1007/s11940-002-0006-4.

Sleep disorders commonly complicate the course following traumatic brain injury (TBI). Insomnia, excessive daytime somnolence and alteration of the sleep-wake schedule are common disturbances that affect the course of recovery and prognosis in TBI survivors. Few studies, however, have...

Cite
Rao V, Rollings P. Sleep Disturbances Following Traumatic Brain Injury. Curr Treat Options Neurol. 2002;4(1):77-87doi: 10.1007/s11940-002-0006-4.
Rao, V., & Rollings, P. (2002). Sleep Disturbances Following Traumatic Brain Injury. Current treatment options in neurology, 4(1), 77-87. https://doi.org/10.1007/s11940-002-0006-4
Rao, Vani, and Rollings, Pamela. "Sleep Disturbances Following Traumatic Brain Injury." Current treatment options in neurology vol. 4,1 (2002): 77-87. doi: https://doi.org/10.1007/s11940-002-0006-4
Rao V, Rollings P. Sleep Disturbances Following Traumatic Brain Injury. Curr Treat Options Neurol. 2002 Jan;4(1):77-87. doi: 10.1007/s11940-002-0006-4. PMID: 11734105.
Copy Download .nbib Format: NLM
Localization of the mosquito insulin receptor homolog (MIR) in reproducing yellow fever mosquitoes (Aedes aegypti).

Journal of insect physiology

Helbling P, Graf R.
PMID: 12770311
J Insect Physiol. 1998 Dec;44(12):1127-1135. doi: 10.1016/s0022-1910(97)00039-5.

The female mosquito takes a blood meal to produce a batch of eggs. Initiation of egg maturation and growth of oocytes is governed by several endocrine factors. Peptide factors from the brain are involved in this process and some...

Cite
Helbling P, Graf R. Localization of the mosquito insulin receptor homolog (MIR) in reproducing yellow fever mosquitoes (Aedes aegypti). J Insect Physiol. 1998;44(12):1127-1135doi: 10.1016/s0022-1910(97)00039-5.
Helbling, P., & Graf, R. (1998). Localization of the mosquito insulin receptor homolog (MIR) in reproducing yellow fever mosquitoes (Aedes aegypti). Journal of insect physiology, 44(12), 1127-1135. https://doi.org/10.1016/s0022-1910(97)00039-5
Helbling, P, and Graf, R. "Localization of the mosquito insulin receptor homolog (MIR) in reproducing yellow fever mosquitoes (Aedes aegypti)." Journal of insect physiology vol. 44,12 (1998): 1127-1135. doi: https://doi.org/10.1016/s0022-1910(97)00039-5
Helbling P, Graf R. Localization of the mosquito insulin receptor homolog (MIR) in reproducing yellow fever mosquitoes (Aedes aegypti). J Insect Physiol. 1998 Dec;44(12):1127-1135. doi: 10.1016/s0022-1910(97)00039-5. PMID: 12770311.
Copy Download .nbib Format: NLM
Linear constrain relations in biochemical reaction systems III. Sequential application of data reconciliation for sensitive detection of systematic errors.

Biotechnology and bioengineering

van der Heijden RT, Romein B, Heijnen JJ, Hellinga C, Luyben KC.
PMID: 18618845
Biotechnol Bioeng. 1994 Sep 20;44(7):781-91. doi: 10.1002/bit.260440703.

This article presents a method to test the presence of relatively small systematic measurement errors; e.g., those caused by inaccurate calibration or sensor drift. To do this, primary measurements-flow rates and concentrations-are first translated into observed conversions, which should...

Cite
van der Heijden RT, Romein B, Heijnen JJ, et al. Linear constrain relations in biochemical reaction systems III. Sequential application of data reconciliation for sensitive detection of systematic errors. Biotechnol Bioeng. 1994;44(7):781-91doi: 10.1002/bit.260440703.
van der Heijden, R. T., Romein, B., Heijnen, J. J., Hellinga, C., & Luyben, K. C. (1994). Linear constrain relations in biochemical reaction systems III. Sequential application of data reconciliation for sensitive detection of systematic errors. Biotechnology and bioengineering, 44(7), 781-91. https://doi.org/10.1002/bit.260440703
van der Heijden, R T, et al. "Linear constrain relations in biochemical reaction systems III. Sequential application of data reconciliation for sensitive detection of systematic errors." Biotechnology and bioengineering vol. 44,7 (1994): 781-91. doi: https://doi.org/10.1002/bit.260440703
van der Heijden RT, Romein B, Heijnen JJ, Hellinga C, Luyben KC. Linear constrain relations in biochemical reaction systems III. Sequential application of data reconciliation for sensitive detection of systematic errors. Biotechnol Bioeng. 1994 Sep 20;44(7):781-91. doi: 10.1002/bit.260440703. PMID: 18618845.
Copy Download .nbib Format: NLM
Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates.

Biotechnology and bioengineering

van der Heijden RT, Heijnen JJ, Hellinga C, Romein B, Luyben KC.
PMID: 18613305
Biotechnol Bioeng. 1994 Jan 05;43(1):3-10. doi: 10.1002/bit.260430103.

Measurements provide the basis for process monitoring and control as well as for model development and validation. Systematic approaches to increase the accuracy and credibility of the empirical data set are therefore of great value. In (bio)chemical conversions, linear...

Cite
van der Heijden RT, Heijnen JJ, Hellinga C, et al. Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates. Biotechnol Bioeng. 1994;43(1):3-10doi: 10.1002/bit.260430103.
van der Heijden, R. T., Heijnen, J. J., Hellinga, C., Romein, B., & Luyben, K. C. (1994). Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates. Biotechnology and bioengineering, 43(1), 3-10. https://doi.org/10.1002/bit.260430103
van der Heijden, R T, et al. "Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates." Biotechnology and bioengineering vol. 43,1 (1994): 3-10. doi: https://doi.org/10.1002/bit.260430103
van der Heijden RT, Heijnen JJ, Hellinga C, Romein B, Luyben KC. Linear constraint relations in biochemical reaction systems: I. Classification of the calculability and the balanceability of conversion rates. Biotechnol Bioeng. 1994 Jan 05;43(1):3-10. doi: 10.1002/bit.260430103. PMID: 18613305.
Copy Download .nbib Format: NLM
An efficient model development strategy for bioprocesses based on neural networks in macroscopic balances.

Biotechnology and bioengineering

van Can HJ, Te Braake HA, Hellinga C, Luyben KC.
PMID: 18636411
Biotechnol Bioeng. 1997 Jun 20;54(6):549-66. doi: 10.1002/(SICI)1097-0290(19970620)54:6<549::AID-BIT6>3.0.CO;2-J.

In the serial gray box modeling strategy, generally available knowledge, represented in the macroscopic balance, is combined naturally with neural networks, which are powerful and convenient tools to model the inaccurately known terms in the macroscopic balance. This article...

Cite
van Can HJ, Te Braake HA, Hellinga C, et al. An efficient model development strategy for bioprocesses based on neural networks in macroscopic balances. Biotechnol Bioeng. 1997;54(6):549-66doi: 10.1002/(SICI)1097-0290(19970620)54:6<549::AID-BIT6>3.0.CO;2-J.
van Can, H. J., Te Braake, H. A., Hellinga, C., & Luyben, K. C. (1997). An efficient model development strategy for bioprocesses based on neural networks in macroscopic balances. Biotechnology and bioengineering, 54(6), 549-66. https://doi.org/10.1002/(SICI)1097-0290(19970620)54:6<549::AID-BIT6>3.0.CO;2-J
van Can, H J, et al. "An efficient model development strategy for bioprocesses based on neural networks in macroscopic balances." Biotechnology and bioengineering vol. 54,6 (1997): 549-66. doi: https://doi.org/10.1002/(SICI)1097-0290(19970620)54:6<549::AID-BIT6>3.0.CO;2-J
van Can HJ, Te Braake HA, Hellinga C, Luyben KC. An efficient model development strategy for bioprocesses based on neural networks in macroscopic balances. Biotechnol Bioeng. 1997 Jun 20;54(6):549-66. doi: 10.1002/(SICI)1097-0290(19970620)54:6<549::AID-BIT6>3.0.CO;2-J. PMID: 18636411.
Copy Download .nbib Format: NLM
T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination.

Expert review of clinical immunology

Hellings N, Raus J, Stinissen P.
PMID: 20477626
Expert Rev Clin Immunol. 2006 Sep;2(5):705-16. doi: 10.1586/1744666X.2.5.705.

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS with presumed autoimmune origin. Pathogenic autoimmune responses in MS are thought to be the result of a breakdown of self tolerance. Several mechanisms account for the natural state...

Cite
Hellings N, Raus J, Stinissen P. T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination. Expert Rev Clin Immunol. 2006;2(5):705-16doi: 10.1586/1744666X.2.5.705.
Hellings, N., Raus, J., & Stinissen, P. (2006). T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination. Expert review of clinical immunology, 2(5), 705-16. https://doi.org/10.1586/1744666X.2.5.705
Hellings, Niels, et al. "T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination." Expert review of clinical immunology vol. 2,5 (2006): 705-16. doi: https://doi.org/10.1586/1744666X.2.5.705
Hellings N, Raus J, Stinissen P. T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination. Expert Rev Clin Immunol. 2006 Sep;2(5):705-16. doi: 10.1586/1744666X.2.5.705. PMID: 20477626.
Copy Download .nbib Format: NLM
Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting.

Journal of patient safety

Desmedt M, Bergs J, Willaert B, Schrooten W, Vlayen A, Hellings J, Claes N, Vandijck D.
PMID: 29394195
J Patient Saf. 2021 Dec 01;17(8):e1216-e1222. doi: 10.1097/PTS.0000000000000458.

OBJECTIVES: The primary aim was to measure patient safety culture in two home care services in Belgium (Flanders). In addition, variability based on respondents' profession was examined.METHODS: A cross-sectional study was conducted by administering the SCOPE-Primary Care questionnaire in...

Cite
Desmedt M, Bergs J, Willaert B, et al. Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting. J Patient Saf. 2021;17(8):e1216-e1222doi: 10.1097/PTS.0000000000000458.
Desmedt, M., Bergs, J., Willaert, B., Schrooten, W., Vlayen, A., Hellings, J., Claes, N., & Vandijck, D. (2021). Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting. Journal of patient safety, 17(8), e1216-e1222. https://doi.org/10.1097/PTS.0000000000000458
Desmedt, Melissa, et al. "Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting." Journal of patient safety vol. 17,8 (2021): e1216-e1222. doi: https://doi.org/10.1097/PTS.0000000000000458
Desmedt M, Bergs J, Willaert B, Schrooten W, Vlayen A, Hellings J, Claes N, Vandijck D. Exploring and Evaluating Patient Safety Culture in a Community-Based Primary Care Setting. J Patient Saf. 2021 Dec 01;17(8):e1216-e1222. doi: 10.1097/PTS.0000000000000458. PMID: 29394195.
Copy Download .nbib Format: NLM
Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement.

Clinical and translational allergy

Hellings PW, Pugin B, Mariën G, Bachert C, Breynaert C, Bullens DM, Ceuppens JL, Clement G, Cox T, Ebo D, Gevaert P, Halewyck S, Hox V, Ladha K, Jacobs R, Rombaux P, Schrijvers R, Speleman K, Van der Brempt X, Van Gerven L, Vanderveken O, Verhaeghe B, Vierstraete K, Vlaminck S, Watelet JB, Bousquet J, Seys SF.
PMID: 30740211
Clin Transl Allergy. 2019 Feb 04;9:1. doi: 10.1186/s13601-019-0243-1. eCollection 2019.

Allergic rhinitis (AR) affects 23-30% of the European population with equal prevalence reported in Belgium. Despite guidelines on the correct use of effective treatment, up to 40% of AR patients remain uncontrolled. Allergen immunotherapy (AIT) has been shown to...

Cite
Hellings PW, Pugin B, Mariën G, et al. Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement. Clin Transl Allergy. 2019;9:1doi: 10.1186/s13601-019-0243-1.
Hellings, P. W., Pugin, B., Mariën, G., Bachert, C., Breynaert, C., Bullens, D. M., Ceuppens, J. L., Clement, G., Cox, T., Ebo, D., Gevaert, P., Halewyck, S., Hox, V., Ladha, K., Jacobs, R., Rombaux, P., Schrijvers, R., Speleman, K., Van der Brempt, X., Van Gerven, L., Vanderveken, O., Verhaeghe, B., Vierstraete, K., Vlaminck, S., Watelet, J. B., Bousquet, J., & Seys, S. F. (2019). Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement. Clinical and translational allergy, 91. https://doi.org/10.1186/s13601-019-0243-1
Hellings, P W, et al. "Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement." Clinical and translational allergy vol. 9 (2019): 1. doi: https://doi.org/10.1186/s13601-019-0243-1
Hellings PW, Pugin B, Mariën G, Bachert C, Breynaert C, Bullens DM, Ceuppens JL, Clement G, Cox T, Ebo D, Gevaert P, Halewyck S, Hox V, Ladha K, Jacobs R, Rombaux P, Schrijvers R, Speleman K, Van der Brempt X, Van Gerven L, Vanderveken O, Verhaeghe B, Vierstraete K, Vlaminck S, Watelet JB, Bousquet J, Seys SF. Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement. Clin Transl Allergy. 2019 Feb 04;9:1. doi: 10.1186/s13601-019-0243-1. eCollection 2019. PMID: 30740211; PMCID: PMC6360767.
Copy Download .nbib Format: NLM
Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis.

Critical reviews in immunology

Dhaeze T, Hellings N.
PMID: 28845757
Crit Rev Immunol. 2016;36(6):511-522. doi: 10.1615/CritRevImmunol.2017019850.

Follicular regulatory T cells (TFRs) are a subset of regulatory T cells that reside in the secondary lymphoid organs and participate in controlling the germinal center (GC) response. The GC response forms the basis of adaptive immunity to foreign...

Cite
Dhaeze T, Hellings N. Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis. Crit Rev Immunol. 2016;36(6):511-522doi: 10.1615/CritRevImmunol.2017019850.
Dhaeze, T., & Hellings, N. (2016). Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis. Critical reviews in immunology, 36(6), 511-522. https://doi.org/10.1615/CritRevImmunol.2017019850
Dhaeze, Tessa, and Hellings, Niels. "Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis." Critical reviews in immunology vol. 36,6 (2016): 511-522. doi: https://doi.org/10.1615/CritRevImmunol.2017019850
Dhaeze T, Hellings N. Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis. Crit Rev Immunol. 2016;36(6):511-522. doi: 10.1615/CritRevImmunol.2017019850. PMID: 28845757.
Copy Download .nbib Format: NLM
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.

Clinical pharmacology and therapeutics

Febbo PG, Martin AM, Scher HI, Barrett JC, Beaver JA, Beresford PJ, Blumenthal GM, Bramlett K, Compton C, Dittamore R, Eberhard DA, Edelstein D, Godsey J, Gruen A, Hanlon SE, Hicks J, Hovelson D, Hullings M, Johann D, Johnson J, Kolatkar A, Kuhn P, Levine R, Martini JF, Miller DP, Moore C, Moy B, Pathak A, Philip R, Reese D, Royalty W, Ryder M, Sakul H, Salvatore LM, Schade A, Silvestro A, Simmons JK, Simons J, Singh Bhan S, Smalley MD, Somiari SB, Talasaz A, Tewari M, Tseng HR, Vinson J, Wells W, Welsh A, Grossman RL, Lee JSH, Leiman LC.
PMID: 32017048
Clin Pharmacol Ther. 2020 Apr;107(4):730-734. doi: 10.1002/cpt.1747. Epub 2020 Feb 04.

No abstract available.

Cite
Febbo PG, Martin AM, Scher HI, et al. Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clin Pharmacol Ther. 2020;107(4):730-734doi: 10.1002/cpt.1747.
Febbo, P. G., Martin, A. M., Scher, H. I., Barrett, J. C., Beaver, J. A., Beresford, P. J., Blumenthal, G. M., Bramlett, K., Compton, C., Dittamore, R., Eberhard, D. A., Edelstein, D., Godsey, J., Gruen, A., Hanlon, S. E., Hicks, J., Hovelson, D., Hullings, M., Johann, D., Johnson, J., Kolatkar, A., Kuhn, P., Levine, R., Martini, J. F., Miller, D. P., Moore, C., Moy, B., Pathak, A., Philip, R., Reese, D., Royalty, W., Ryder, M., Sakul, H., Salvatore, L. M., Schade, A., Silvestro, A., Simmons, J. K., Simons, J., Singh Bhan, S., Smalley, M. D., Somiari, S. B., Talasaz, A., Tewari, M., Tseng, H. R., Vinson, J., Wells, W., Welsh, A., Grossman, R. L., Lee, J. S. H., & Leiman, L. C. (2020). Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clinical pharmacology and therapeutics, 107(4), 730-734. https://doi.org/10.1002/cpt.1747
Febbo, Phillip G, et al. "Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases." Clinical pharmacology and therapeutics vol. 107,4 (2020): 730-734. doi: https://doi.org/10.1002/cpt.1747
Febbo PG, Martin AM, Scher HI, Barrett JC, Beaver JA, Beresford PJ, Blumenthal GM, Bramlett K, Compton C, Dittamore R, Eberhard DA, Edelstein D, Godsey J, Gruen A, Hanlon SE, Hicks J, Hovelson D, Hullings M, Johann D, Johnson J, Kolatkar A, Kuhn P, Levine R, Martini JF, Miller DP, Moore C, Moy B, Pathak A, Philip R, Reese D, Royalty W, Ryder M, Sakul H, Salvatore LM, Schade A, Silvestro A, Simmons JK, Simons J, Singh Bhan S, Smalley MD, Somiari SB, Talasaz A, Tewari M, Tseng HR, Vinson J, Wells W, Welsh A, Grossman RL, Lee JSH, Leiman LC. Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clin Pharmacol Ther. 2020 Apr;107(4):730-734. doi: 10.1002/cpt.1747. Epub 2020 Feb 04. PMID: 32017048; PMCID: PMC7158216.
Copy Download .nbib Format: NLM
Corrigendum: Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes.

Scientific reports

Bogie JFJ, Mailleux J, Wouters E, Jorissen W, Grajchen E, Vanmol J, Wouters K, Hellings N, Horssen JV, Vanmierlo T, Hendriks JJA.
PMID: 29271403
Sci Rep. 2017 Dec 22;7:46925. doi: 10.1038/srep46925.

This corrects the article DOI: 10.1038/srep44794.

Cite
Bogie JFJ, Mailleux J, Wouters E, et al. Corrigendum: Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes. Sci Rep. 2017;7:46925doi: 10.1038/srep46925.
Bogie, J. F. J., Mailleux, J., Wouters, E., Jorissen, W., Grajchen, E., Vanmol, J., Wouters, K., Hellings, N., Horssen, J. V., Vanmierlo, T., & Hendriks, J. J. A. (2017). Corrigendum: Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes. Scientific reports, 746925. https://doi.org/10.1038/srep46925
Bogie, Jeroen F J, et al. "Corrigendum: Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes." Scientific reports vol. 7 (2017): 46925. doi: https://doi.org/10.1038/srep46925
Bogie JFJ, Mailleux J, Wouters E, Jorissen W, Grajchen E, Vanmol J, Wouters K, Hellings N, Horssen JV, Vanmierlo T, Hendriks JJA. Corrigendum: Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes. Sci Rep. 2017 Dec 22;7:46925. doi: 10.1038/srep46925. PMID: 29271403; PMCID: PMC5740735.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 174 entries